PL348513A1 - Novel nucleic acid transferring agents, compositions containing them and uses - Google Patents

Novel nucleic acid transferring agents, compositions containing them and uses

Info

Publication number
PL348513A1
PL348513A1 PL99348513A PL34851399A PL348513A1 PL 348513 A1 PL348513 A1 PL 348513A1 PL 99348513 A PL99348513 A PL 99348513A PL 34851399 A PL34851399 A PL 34851399A PL 348513 A1 PL348513 A1 PL 348513A1
Authority
PL
Poland
Prior art keywords
nucleic acid
compositions containing
novel nucleic
transferring agents
acid transferring
Prior art date
Application number
PL99348513A
Other languages
English (en)
Inventor
Jean Herscovici
Hans Hofland
Christophe Jacopin
Daniel Scherman
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9815309A external-priority patent/FR2786700B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PL348513A1 publication Critical patent/PL348513A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL99348513A 1998-12-03 1999-12-02 Novel nucleic acid transferring agents, compositions containing them and uses PL348513A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9815309A FR2786700B1 (fr) 1998-12-03 1998-12-03 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
US11718499P 1999-01-26 1999-01-26
PCT/FR1999/002995 WO2000032803A2 (fr) 1998-12-03 1999-12-02 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations

Publications (1)

Publication Number Publication Date
PL348513A1 true PL348513A1 (en) 2002-06-03

Family

ID=26234691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348513A PL348513A1 (en) 1998-12-03 1999-12-02 Novel nucleic acid transferring agents, compositions containing them and uses

Country Status (13)

Country Link
EP (1) EP1137793A2 (cs)
JP (1) JP2002531468A (cs)
KR (1) KR20010101116A (cs)
CN (1) CN1348498A (cs)
AU (1) AU772033B2 (cs)
BR (1) BR9915897A (cs)
CA (1) CA2353576A1 (cs)
CZ (1) CZ20011909A3 (cs)
HU (1) HUP0200345A3 (cs)
IL (1) IL142704A0 (cs)
NO (1) NO20012684L (cs)
PL (1) PL348513A1 (cs)
WO (1) WO2000032803A2 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
JP2005080598A (ja) * 2003-09-10 2005-03-31 Japan Science & Technology Agency β−1,3−グルカン誘導体を用いるプラスミドDNAの導入法
CN103820320B (zh) * 2013-06-25 2017-03-15 宁波有成生物医药科技有限公司 一种非冻型rna保护液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4690596A (en) * 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
CZ20011909A3 (cs) 2001-09-12
EP1137793A2 (fr) 2001-10-04
WO2000032803A3 (fr) 2000-10-12
NO20012684L (no) 2001-07-30
HUP0200345A2 (hu) 2002-05-29
HUP0200345A3 (en) 2003-12-29
BR9915897A (pt) 2001-08-21
AU772033B2 (en) 2004-04-08
WO2000032803A2 (fr) 2000-06-08
IL142704A0 (en) 2002-03-10
JP2002531468A (ja) 2002-09-24
NO20012684D0 (no) 2001-05-31
AU1564600A (en) 2000-06-19
KR20010101116A (ko) 2001-11-14
CA2353576A1 (fr) 2000-06-08
CN1348498A (zh) 2002-05-08

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
PL342081A1 (en) Novel quaternary ammonia compounds, compositions containing them and their application
AP9901505A0 (en) (4-arylsulfonylamino)- etrah dropyran-4-carboxylic acid hydroxamides
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
PL338186A1 (en) Beneficial agent compositions containing alpha-hydroxyesters
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
AU4289399A (en) Nucleic acid transfer phage
HUP0004375A3 (en) Composition containing azelaic acid
PL334568A1 (en) Paroxetin containing compositions
HUP0102413A3 (en) Nucleic acid transfer vectors, compositions containing same and uses
PL342165A1 (en) Antienzymic composition containing ethylenediamino disuscinic acid
IL142704A0 (en) Novel nucleic acid transferring agents, compositions containing them and uses
GB9704643D0 (en) Chemical composition
GB9715908D0 (en) Chemical composition
PL342886A1 (en) Novel nucleic acid transfer agents, compositions containing same and uses
GB9923882D0 (en) Chemical composition
GB9816132D0 (en) Non-aqueous anthelmintic composition
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
GB9819600D0 (en) Chemical compositions
AU3895499A (en) Methods and compositions for nucleic acid delivery
GB9822490D0 (en) Nucleic acid
GB9823481D0 (en) Nucleic acid
AUPP704498A0 (en) Nucleic acid sequence
GB9709829D0 (en) Chemical compositions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)